TIVENIX
TIVENIX
Tivenix’s proprietary software diagnostic can analyse and interpret complex epigenetic patterns in plasma with accuracy matching current best clinical practice for AD diagnostics. Our platform is engineered to easily integrate with data from other biomarkers.
TIVENIX
We can detect and characterize neuronal loss in blood samples. Our proof-of-concept study demonstrated the accuracy of our biomarker for Alzheimer’s disease. We are now conducting a confirmatory study to validate our results and expand our scope to other neurodegenerative diseases.
TIVENIX
We are a Swiss company with a team of experts in neuroscience, biotechnology, data science, and software engineering. We are committed to innovation, excellence, and social impact. We believe that our technology can make a difference in the fight against Alzheimer’s disease and improve the lives of millions of people around the world.
Board of Directors
Luca Soncini
Chairman
Paolo Paganetti
Board member
Management team
Luca Colnaghi
Advisor
TIVENIX
We are thrilled to announce that Miro Venturi has joined Tivenix SA as a board member! Miro brings a wealth of experience and expertise to our team, and we’re incredibly excited to have him on board. His strategic vision and
This is a significant milestone in our journey, as it will provide us with valuable support and guidance to further enhance our product and business. It also marks a motivating second endorsement of our hard work, building on the innovation
TIVENIX